Identification of Novel Biomarkers in Pancreatic Tumor Tissue to Predict Response to Neoadjuvant Chemotherapy

Frontiers in Oncology - Switzerland
doi 10.3389/fonc.2020.00237
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Frontiers Media SA

Related search

Molecular Biomarkers to Predict Response to Neoadjuvant Chemotherapy for Bladder Cancer

Cancer Treatment Reviews
MedicineOncologyRadiologyNuclear MedicineImaging
2017English

Multiagent Neoadjuvant Chemotherapy and Tumor Response Are Associated With Improved Survival in Pancreatic Cancer

HPB
HepatologyGastroenterology
2019English

Identification of Biomarkers Including 18fdg-Pet/Ct for Early Prediction of Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer

Clinical Cancer Research
Cancer ResearchOncology
2015English

Pathologic Tumor Response to Neoadjuvant Chemotherapy in Gastroesophageal Cancer: What Does It Mean?

Translational Gastroenterology and Hepatology
2016English

Deletions of Multidrug Resistance Gene Loci in Breast Cancer Leads to the Down-Regulation of Its Expression and Predict Tumor Response to Neoadjuvant Chemotherapy

Oncotarget
Oncology
2016English

Integration of Pathologic Findings With Clinical-Radiologic Tumor Measurements to Quantify Response to Neoadjuvant Chemotherapy

2003English

Monitoring the Responsiveness of T and Antigen Presenting Cell Compartments in Breast Cancer Patients Is Useful to Predict Clinical Tumor Response to Neoadjuvant Chemotherapy

BMC Cancer
Cancer ResearchOncologyGenetics
2018English

Sustained CA19-9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival

Oncologist
Cancer ResearchMedicineOncology
2020English

Indoleamine-2,3-Dioxygenase and Interleukin-6 Associated With Tumor Response to Neoadjuvant Chemotherapy in Breast Cancer

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy